[go: up one dir, main page]

HK1186961A - Methods for enhancing immunogen specific immune responses by vectored vaccines - Google Patents

Methods for enhancing immunogen specific immune responses by vectored vaccines Download PDF

Info

Publication number
HK1186961A
HK1186961A HK13114355.5A HK13114355A HK1186961A HK 1186961 A HK1186961 A HK 1186961A HK 13114355 A HK13114355 A HK 13114355A HK 1186961 A HK1186961 A HK 1186961A
Authority
HK
Hong Kong
Prior art keywords
methods
specific immune
immune responses
vectored vaccines
immunogen specific
Prior art date
Application number
HK13114355.5A
Other languages
Chinese (zh)
Inventor
Thomas W. Dubensky, Jr.
Jared M. ODEGARD
Scott H. ROBBINS
Original Assignee
Immune Design Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immune Design Corp. filed Critical Immune Design Corp.
Publication of HK1186961A publication Critical patent/HK1186961A/en

Links

Abstract

Provided herein are methods for inducing a specific immune response in a subject by administering to the subject an immunogenic composition comprising a recombinant expression vector, or a vector particle comprising the recombinant expression vector, which vector comprises a polynucleotide sequence that encodes an immunogen of interest. The methods further comprise administering an adjuvant composition either concurrently or sequentially with the immunogenic composition.
HK13114355.5A 2011-02-15 2012-02-15 Methods for enhancing immunogen specific immune responses by vectored vaccines HK1186961A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61/443,194 2011-02-15

Publications (1)

Publication Number Publication Date
HK1186961A true HK1186961A (en) 2014-03-28

Family

ID=

Similar Documents

Publication Publication Date Title
EA201391183A1 (en) METHODS OF STRENGTHENING IMMUNOGENSPECIFIC IMMUNE RESPONSES WITH THE HELP OF VECTOR VECTIONS
WO2013054199A3 (en) Cmv antigens and uses thereof
MX365391B (en) Novel prime-boosting regimens involving immunogenic polypeptides encoded by polynucleotides.
WO2015142671A3 (en) Influenza virus vectors and uses therefor
MX2015008847A (en) Influenza virus immunogenic compositions and uses thereof.
WO2014018858A3 (en) Multimeric fusion protein vaccine and immunotherapeutic
EP4494650A3 (en) Vaccine compositions having improved stability and immunogenicity
HK1225631A1 (en) Immunogenic middle east respiratory syndrome coronavirus (mers-cov) compositions and methods
WO2013143683A8 (en) Rna formulation for immunotherapy
WO2011103453A3 (en) Vaccines for use in the prophylaxis and treatment of influenza virus disease
WO2016019134A8 (en) Flagellin-based agents and uses including effective vaccination
EA201290675A1 (en) VACCINE VECTORS AND METHODS OF STRENGTHENING IMMUNE RESPONSES
WO2014107652A3 (en) Vaccines with higher carbohydrate antigen density and novel saponin adjuvant
WO2014136064A3 (en) Immunogenic fusion polypeptides
WO2012125551A8 (en) Listeria-based adjuvants
MX2014009845A (en) Recombinant poxviral vectors expressing both rabies and ox40 proteins, and vaccines made therefrom.
PH12015500956B1 (en) Novel mucosal adjuvants and delivery systems
HK1219045A1 (en) Compositions and methods of enhancing immune responses to enteric pathogens
WO2013188627A3 (en) Cationic lipid vaccine compositions and methods of use
WO2008148057A3 (en) Cationic lipids compositions and methods for enhancing immune responses to vaccines
PH12015501716B1 (en) Anti-mycoplasma spp. subunit vaccine
NZ715459A (en) A hyperbarically-inactivated microorganism, immunogenic compositions comprising same and methods for producing same
GB201017519D0 (en) Vaccines
PH12014501795B1 (en) Rotavirus subunit vaccines and methods of making and use thereof
EP3908315A4 (en) Compositions and methods for enhancing immune response to vaccination and improving vaccine production